Dahlia Biosciences

Drug Discovery · Molecular Diagnostics

Overview

Dahlia Biosciences specializes in high-quality RNA Flow Assays for scientists in pharmaceuticals, biotechnology, and academia. Explore our products and elevate your research capabilities.

Funding and backers

Team
11-50
employees, estimated range
Backers
1
SOSV
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Arda TherapeuticsSeries A $43.3M · 2 yr ago · Founded 2021 · 51-200 employees · 2 roles
Arda Therapeutics is a biotechnology company that develops medicines which target and deplete pathogenic cells rather than single proteins…
KiloGen Therapeutics specializes in proximity pharmacology, molecular glues, targeted protein degradation (TPD), biotechnology, drug…
Plasmidsaurus51-200 employees · 15 roles
Plasmidsaurus is the sequencing infrastructure for modern biology. Founded by scientists, for scientists, it was built around a simple…
Immunoassays for any Protein, any Specimen and any Species. SIGNATOPE offers next generation quantitative assays for your protein biomarker…
Psylink is a biotechnology company offering a novel solution to psychedelic drug development.
CytorumVenture round $150k · 4 yr ago · Founded 2020 · 11-50 employees
We provide next generation fluorescence, spectral, and mass cytometry services. Project design, wet lab assay development, and advanced…

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
SOSVVia a fund
780 portfolio companies